SOST and sarcopenia: Medeiros et al. (2020) reported on a study involving hemodialysis patients with diabetes and illustrated that sclerostin proportion is higher in patients with type 2 diabetes mellitus compared to healthy controls, possibly indicating that a positive relationship between sclerostin and sarcopenia exists.